These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6744872)

  • 21. Follow-up of long-time treatment with intravesical oxybutynin for neurogenic bladder in children.
    Amark P; Bussman G; Eksborg S
    Eur Urol; 1998 Aug; 34(2):148-53. PubMed ID: 9693251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vesicoureteral reflux: the importance of etiology in management.
    King LR; Surian MA; Wendel RM; Burden JJ
    Trans Am Assoc Genitourin Surg; 1967; 59():110-5. PubMed ID: 6064514
    [No Abstract]   [Full Text] [Related]  

  • 23. Experiences with vesicoureteral reflux.
    Brannan W; Ochsner MG; Rosencrantz DR; Whitehead CM; Goodier EH
    J Urol; 1973 Jan; 109(1):46-8. PubMed ID: 4684547
    [No Abstract]   [Full Text] [Related]  

  • 24. Fate of vesicoureteral reflux in children with neuropathic bladders managed by intermittent catheterization.
    Kass EJ; Koff SA; Diokno AC
    J Urol; 1981 Jan; 125(1):63-4. PubMed ID: 7463586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative characteristics of stimulant cystotonometry in children].
    Salov PP; Tokarenko NS; Zakharova NS
    Pediatriia; 1989; (2):95-6. PubMed ID: 2726378
    [No Abstract]   [Full Text] [Related]  

  • 26. Vesicoureteral reflux: a comparison of non-surgical and surgical management.
    Bellinger MF; Duckett JW
    Contrib Nephrol; 1984; 39():81-93. PubMed ID: 6744882
    [No Abstract]   [Full Text] [Related]  

  • 27. Is a secondary procedure necessary in every case of failed endoscopic treatment for vesicoureteral reflux?
    Jung HJ; Im YJ; Lee YS; Kim MJ; Han SW
    Korean J Urol; 2015 May; 56(5):398-404. PubMed ID: 25964842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent advances in the treatment of non-obstructive urinary tract infection in infants and children.
    Manz F; Mehls O
    Paediatr Indones; 1982; 22(11-12):235-47. PubMed ID: 6763670
    [No Abstract]   [Full Text] [Related]  

  • 29. Principles of management of the complications of the neurogenic bladder.
    Jameson RM
    Paraplegia; 1968 Nov; 6(3):162-8. PubMed ID: 5709947
    [No Abstract]   [Full Text] [Related]  

  • 30. Follow-up of clean intermittent catheterization for children with neurogenic bladders.
    Lin-Dyken DC; Wolraich ML; Hawtrey CE; Doja MS
    Urology; 1992 Dec; 40(6):525-9. PubMed ID: 1466106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bladder-sphincter dysfunction in childhood.
    Koff SA
    Urology; 1982 May; 19(5):457-61. PubMed ID: 7080315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of vesicoureteral reflux secondary to neurogenic bladder.
    Morioka A; Miyano T; Ando K; Yamataka T; Lane GJ
    Pediatr Surg Int; 1998 Oct; 13(8):584-6. PubMed ID: 9799381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of vesicoureteral reflux and urinary tract infection in children.
    Wacksman J; Kallen RJ
    Ohio State Med J; 1979 Mar; 75(3):129-31. PubMed ID: 424149
    [No Abstract]   [Full Text] [Related]  

  • 34. [Combination of oxybutynin chloride (Ditropan) with intermittent catheterization in the treatment of neurogenic bladder in childhood: results on continence].
    De Castro R; Casolari E; Ricci S
    Pediatr Med Chir; 1984; 6(6):795-803. PubMed ID: 6545593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vesicoureteral reflux in adults. A twelve-year study of 122 patients.
    Amar AD; Singer B; Lewis R; Nocks B
    Urology; 1974 Feb; 3(2):184-9. PubMed ID: 4204756
    [No Abstract]   [Full Text] [Related]  

  • 36. Acute effect of sacral neuromodulation on video-urodynamic parameters of neurogenic lower urinary tract dysfunction in a patient with vesicoureteral reflux: a case report.
    Meng L; Tian Z; Wang M; Liu X; Ma T; Wang J; Zhang W; Zhang Y
    Ann Palliat Med; 2022 Apr; 11(4):1568-1574. PubMed ID: 35523758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of urinary tract infection and vesicoureteral reflux in children with lower urinary tract dysfunction.
    Van Batavia JP; Ahn JJ; Fast AM; Combs AJ; Glassberg KI
    J Urol; 2013 Oct; 190(4 Suppl):1495-9. PubMed ID: 23416636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The management of vesicoureteral reflux in children with neurogenic bladders.
    Kass EJ; Koff SA
    Z Kinderchir; 1981 Dec; 34(4):379-83. PubMed ID: 7331545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Swedish Infant High-grade Reflux Trial - Bladder function.
    Nordenström J; Sillen U; Holmdahl G; Linnér T; Stokland E; Sjöström S
    J Pediatr Urol; 2017 Apr; 13(2):139-145. PubMed ID: 27989639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysfunctional voiding: a complex of bladder/sphincter dysfunction, urinary tract infections and vesicoureteral reflux.
    van Gool JD
    Acta Urol Belg; 1995 Sep; 63(3):27-33. PubMed ID: 7484519
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.